Manas Jaiswal of manasjaiswal.com has a buy call on Strides Pharma Science Ltd.

with a target price of Rs 495.

The current market price of Strides Pharma Science Ltd.

is Rs 476.05.

Time period given by analyst is Intra Day when Strides Pharma Science Ltd.

price can reach defined target.

Manas Jaiswal recommended to keep stoploss at Rs 465.

Strides Pharma Science Ltd., incorporated in 1990, is a midcap company with a market cap of Rs 4262.98 crore. Strides Pharma Science Ltd.

key Products/Revenue Segments include Pharmaceuticals which contributed Rs 1270.91 Crore to Sales Value (86.47 % of Total Sales), Other Operating Revenue which contributed Rs 111.92 Crore to Sales Value (7.61 % of Total Sales), Sale of services which contributed Rs 36.46 Crore to Sales Value (2.48 % of Total Sales), Royalty Income which contributed Rs 26.92 Crore to Sales Value (1.83 % of Total Sales) and Export Incentives which contributed Rs 23.40 Crore to Sales Value (1.59 % of Total Sales)for year ending 31-Mar-2018.

For quarter ended 30-09-2018, company has reported a Consolidated sales of Rs 732.63 Crore, up 10.43 % from last quarter Sales of Rs 663.46 Crore and down -26.41 % from last year same quarter Sales of Rs 995.60 Crore Company has reported net profit after tax of Rs 3.60 Crore in latest quarter.

The company’s top management includes Mr.Arun Kumar, Mr.Badree Komandur, Mr.Bharat D Shah, Mr.Deepak Vaidya, Mr.Homi Rustam Khusrokhan, Mr.S Sridhar, Ms.Sangita Reddy.

Company has BSR Co.

LLP as its auditoRs As on 30-09-2018, company has a total of 89,548,913 shares outstanding.